HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy of 1-week ranitidine-bismuth-citrate (RBC)-based triple therapy for eradication of Helicobacter pylori infection.

AuthorsV Savarino, S Vigneri
JournalAlimentary pharmacology & therapeutics (Aliment Pharmacol Ther) Vol. 13 Issue 9 Pg. 1251-2 (Sep 1999) ISSN: 0269-2813 [Print] England
PMID10468709 (Publication Type: Letter, Comment)
Chemical References
  • Antacids
  • Anti-Bacterial Agents
  • Anti-Ulcer Agents
  • Organometallic Compounds
  • Metronidazole
  • Ranitidine
  • bismuth tripotassium dicitrate
Topics
  • Antacids (administration & dosage)
  • Anti-Bacterial Agents (administration & dosage)
  • Anti-Ulcer Agents (administration & dosage)
  • Clinical Trials as Topic
  • Drug Therapy, Combination
  • Helicobacter Infections (drug therapy)
  • Helicobacter pylori
  • Humans
  • Metronidazole (administration & dosage)
  • Organometallic Compounds (administration & dosage)
  • Ranitidine (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: